Skip to content

CRBU - Caribou Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Caribou Biosciences Inc

CRBU · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CRBUCaribou Biosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.54
52-wk low: $1.38
Prev close: $2.45
Mkt cap: $175.8M
Beta: 2.28
P/S: 17.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$29.2M

JS
Jim Simons
Q2 2026 13F
$4.9M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 27.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $176M

Valuation

P/S17.52
P/B1.69

Quality

Operating margin-1690.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CRBU
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $175.82M
Beta: 2.28

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.7x

Profit margin

+0.0%

Op margin

-1690.0%

ROE

-78.3%

$1.8M

position

MC

Maverick Capital

Lee Ainslie · Q2 2026 13F

$1.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CRBU

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.24+27.3%

-$0.33 expected

Next report

What the street expects next

EPS expected

-$0.30

-$0.33 to -$0.27

Revenue expected

$2.2M

6 analysts

Estimate drift

+0.02

Change in 30 days

-78.3%

ROA-36.8%

Growth

Beta2.28